title: Mary B. Walker, M.D. and the pioneering use of prostigmin to treat myasthenia gravis.
abstract: In an era when women were not admitted to the University of Edinburgh and when England's first female physician (Elizabeth Garrett Anderson, 1836-1917) had to venture to Paris, France, to earn her M.D. in 1870, the career of Mary Broadfoot Walker (Figure 1) (1988-1974) stands out for truly remarkable achievement. She is credited with making the most significant discovery in medical therapeutic within the British empire.
authors.affiliation: University of Louisville, School of Medicine, KY 40292, USA.
authors.forename: A H
authors.initials: AH
authors.lastname: Keeney
authors.forename: V T
authors.initials: VT
authors.lastname: Keeney
mesh_terms: D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000266:history*; D009388:Neostigmine / Q000266:history* / Q000627:therapeutic use; D009885:Ophthalmology / Q000266:history*; D006113:United Kingdom
chemical_list: D009388:Neostigmine